نتائج البحث

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing (BASECAMP-1)

• Authors : Tempus AI

• Source: An Observational Study Obtaining Solid Tumor Tissue from Participants and Apheresis for CAR T-Cell Therapy ManufacturingAmerican Cancer Society. Cancer Facts & Figures 2021. Atlanta: American

تفاصيل العنوان

A Screening Study to Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in Patients With Metastatic Solid Tumors

• Source: Screening Study to Determine HLA Type, HLA Loss of Heterozygosity Status and Tumor Antigen Expression in Participants With Locally

تفاصيل العنوان

Phase III Trial of Anaplastic Glioma Without 1p/19q Loss of Heterozygosity (LOH) (CATNON)

• Authors : NCIC Clinical Trials Group; Radiation Therapy Oncology Group; Medical Research Council

• Source: Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.Tesileanu CMS, Sanson M, Wick W, Brandes AA, Clement PM,

تفاصيل العنوان

Study of Kidney Tumors in Younger Patients

• Authors : National Cancer Institute (NCI)

• Source: Renal Tumors Classification, Biology, and Banking StudyParsons LN, Mullen EA, Geller JI, Chi YY, Khanna G, Glick RD, Aldrink JH, Vallance KL, Kim Y, Fernandez CV, Dome JS, Perlman EJ. Outcome

تفاصيل العنوان

Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor

• Authors : National Cancer Institute (NCI)

• Source: Treatment of Newly Diagnosed Higher Risk Favorable Histology Wilms TumorsMadanat-Harjuoja LM, Renfro LA, Klega K, Tornwall B, Thorner AR, Nag A, Dix D, Dome JS, Diller LR, Fernandez CV, Mullen

تفاصيل العنوان

Genetics of Endocrine Tumours - Familial Isolated Pituitary Adenoma - FIPA

• Source: Genetics of Endocrine Tumours - Familial Isolated Pituitary Adenoma - FIPAHernandez-Ramirez LC, Gabrovska P, Denes J, Stals K, Trivellin G, Tilley D, Ferrau F, Evanson J, Ellard S, Grossman AB,

تفاصيل العنوان

Study of Skin Tumors in Tuberous Sclerosis

• Authors : Uniformed Services University of the Health Sciences

• Source: Cutaneous Tumorigenesis in Patients With Tuberous SclerosisKwiatkowski DJ, Short MP. Tuberous sclerosis. Arch Dermatol. 1994 Mar;130(3):348-54.Weiner DM, Ewalt DH, Roach ES, Hensle TW. The

تفاصيل العنوان

Molecular Characterization of Viral-associated Tumors, Tumors Occurring in the Setting of HIV or Other Immune Disorders and Castleman Disease

• Source: Molecular Characterization of Viral-associated Tumors, Tumors Occurring in the Setting of HIV or Other Immune Disorders and Castleman Disease

تفاصيل العنوان

Mirvetuximab Soravtansine and Rucaparib Camsylate in Treating Participants with Recurrent Endometrial, Ovarian, Fallopian Tube or Primary Peritoneal Cancer

• Authors : ImmunoGen, Inc.; Clovis Oncology, Inc.; Floor Backes, MD, Principal Investigator

• Source: Phase I Study of Mirvetuximab Soravtansine (IMGN853) and Rucaparib for Recurrent Endometrial, Ovarian, Fallopian Tube or Primary Peritoneal Cancer

تفاصيل العنوان

A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants with Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression (DENALI-1)

• Source: A Seamless Phase 1/2 Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated Tmod™ CAR T, in Heterozygous HLA-A*02 Adults with Recurrent Unresectable, Locally Advanced, or

تفاصيل العنوان